Mycoplasma Removal Agent (MRA) was developed to combat the widespread problems caused by contamination of cell cultures with mycoplasma.























 The effect of Mycoplasma Removal Agent (0.5 mg/ml) in the culture media of mycoplasma-infected cells after 1 week.



Basic Protocol

  1. Add MRA to cell cultures contaminated by mycoplasma at a concentration of 0.5 μg/ml and incubate for a week.

  2. For media replacement or culture transfer (passage), use a medium containing MRA at this same concentration.

  3. Transfer the cell cultures several times without MRA and confirm that regrowth of the contaminating mycoplasma has not occurred.

If mycoplasma in serum or trypsin cannot be ruled out, MRA can be added to the media at a concentration of 0.5 μg/ml to prevent contamination of cell cultures exposed to these products.

Note: The recommended MRA concentration for use is 0.5 μg/ml. The MRA concentration should be raised up to 1 μg/ml only if the recommended concentration is ineffective in removing the mycoplasma.

Cytotoxicity of MRA is low and cell toxicity is rare when used at the recommended concentration. However, it is recommended that the retention of desired cellular characteristics be confirmed after treatment.

Note: Mycoplasma Removal Agent should not be used as a substitute for good cell culture techniques!



References:

  1. Nakai, N. et al. (2000). Detection and elimination of contaminating microorganisms in Transplantable Tumors and Cell Lines. Exp. Anim. 49: 309 – 313.

Storage Conditions:

MRA is stable at room temperature. Protect from light to prevent decomposition.

Shelf Life:

5 years from date of despatch.